Assembly Biosciences, Inc.
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14.8M | $9.0M | $0 | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | $72.7M | $44.2M | $33.1M | $18.4M | $10.7M | $15.0M | $19.5M | $25.3M |
| SG&A Expense | $34.8M | $17.0M | $12.2M | $11.3M | $13.2M | $4.6M | $5.3M | $8.7M |
| Operating Income | $-92.7M | $-52.2M | $-45.3M | $-29.7M | $-24.0M | $-19.6M | $-24.9M | $-34.0M |
| Operating Margin | -626.4% | -579.1% | — | — | — | — | — | — |
| Interest Expense | — | — | — | — | — | — | — | $116.7K |
| Pretax Income | $-89.7M | $-51.9M | $-44.9M | $-28.5M | $-23.8M | — | — | — |
| Income Tax Expense | $1.1M | $-9.1M | $-618.0K | $0 | $0 | — | — | — |
| Net Income | $-90.8M | $-42.8M | $-44.3M | $-28.5M | $-23.8M | $-19.4M | $-24.8M | $-34.3M |
| Net Margin | -613.0% | -474.7% | — | — | — | — | — | — |
| EPS (Basic) | $-3.98 | $-2.41 | $-2.57 | $-1.81 | $-3.40 | $-5.00 | $-1.94 | $-3.57 |
| EPS (Diluted) | $-3.98 | $-2.41 | $-2.57 | $-1.81 | $-3.40 | $-5.00 | $-1.94 | $-3.57 |
| Shares Outstanding (Basic) | 25.5M | 20.1M | 17.2M | 17.2M | 10.7M | 4.1M | 12.9M | 12.4M |
| Shares Outstanding (Diluted) | 25.5M | 20.1M | 17.2M | 17.2M | 10.7M | 4.1M | 12.9M | 12.4M |
| Dividends Per Share | — | — | — | — | — | — | — | — |